Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss

Environmental Health Perspectives

Volumn 119, Issue 3, 2011, Pages 377-383

  Kim, Min Ji ^a   Marchand, Philippe ^b   Henegar, Corneliu ^a,c,d   Antignac, Jean Philippe ^b   Alili, Rohia ^a,c,d   Poitou, Christine ^a,c,d   Bouillot, Jean Luc ^e   Basdevant, Arnaud ^a,c,d   le Bizec, Bruno ^b   Barouki, Robert ^a,f   Clément, Karine ^a,c,d  

^a INSERM   (France)

^b LUNAM UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Centre de Recherche en Nutrition Humaine Ile de France   (France)

^e HÔTEL DIEU   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Adipose tissue; Bariatric surgery; Dioxin; Obesity; PCB; Persistent organic pollutants; Xenobiotic metabolizing enzymes

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DIOXIN; FURAN DERIVATIVE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; POLYCHLORINATED BIPHENYL; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGE; ARTICLE; BARIATRIC SURGERY; BIOACCUMULATION; BLOOD LEVEL; BODY BURDEN; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER TOXICITY; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; ARYL HYDROCARBON HYDROXYLASES; BODY BURDEN; CYTOCHROME P-450 CYP1A1; DIOXINS; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); OBESITY; POLYCHLORINATED BIPHENYLS; WEIGHT LOSS;

EID: 79952345424     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1002848     Document Type: Article

References (29)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640-1645.
2. Brewster DW, Matsumura F. 1988. Reduction of adipose tissue lipoprotein lipase activity as a result of in vivo administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin to the guinea pig. Biochem Pharmacol 37(11):2247-2253.
3. Brunt EM. 2010. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7(4):195-203.
4. Charlier C, Desaive C, Plomteux G. 2002. Human exposure to endocrine disrupters: consequences of gastroplasty on plasma concentration of toxic pollutants. Int J Obes Relat Metab Disord 26(11):1465-1468.
5. Chevrier J, Dewailly E, Ayotte P, Mauriege P, Despres JP, Tremblay A. 2000. Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals. Int J Obes Relat Metab Disord 24(10):1272-1278.
6. Dewailly É, Mulvad G, Pedersen HS, Ayotte P, Demers A, Weber JP, et al. 1999. Concentration of organochlorines in human brain, liver, and adipose tissue autopsy samples from Greenland. Environ Health Perspect 107:823-828.
7. Fierens S, Mairesse H, Heilier JF, De Burbure C, Focant JF, Eppe G, et al. 2003. Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers 8(6):529-534.
8. Ha MH, Lee DH, Jacobs DR. 2007. Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: results from the National Health and Nutrition Examination Survey, 1999-2002. Environ Health Perspect 115:1204-1209.
9. Ha MH, Lee DH, Son HK, Park SK, Jacobs DR Jr. 2009. Association between serum concentrations of persistent organic pollutants and prevalence of newly diagnosed hypertension: results from the National Health and Nutrition Examination Survey 1999-2002. J Hum Hypertens 23(4):274-286.
10. Hue O, Marcotte J, Berrigan F, Simoneau M, Dore J, Marceau P, et al. 2006. Increased plasma levels of toxic pollutants accompanying weight loss induced by hypocaloric diet or by bariatric surgery. Obes Surg 16(9):1145-1154.
11. Imbeault P, Chevrier J, Dewailly E, Ayotte P, Despres JP, Mauriege P, et al. 2002. Increase in plasma pollutant levels in response to weight loss is associated with the reduction of fasting insulin levels in men but not in women. Metabolism 51(4):482-486.
12. Lakshman MR, Campbell BS, Chirtel SJ, Ekarohita N. 1988. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on de novo fatty acid and cholesterol synthesis in the rat. Lipids 23(9):904-906.
13. Lee DH, Jacobs DR Jr, Steffes M. 2008. Association of organochlorine pesticides with peripheral neuropathy in patients with diabetes or impaired fasting glucose. Diabetes 57(11):3108-3111.
14. Liu PC, Dunlap DY, Matsumura F. 1998. Suppression of C/EBPalpha and induction of C/EBPbeta by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse adipose tissue and liver. Biochem Pharmacol 55(10):1647-1655.
15. Liu PC, Matsumura F. 2006. TCDD suppresses insulin-responsive glucose transporter (GLUT-4) gene expression through C/EBP nuclear transcription factors in 3T3-L1 adipocytes. J Biochem Mol Toxicol 20(2):79-87.
16. Marchand A, Tomkiewicz C, Marchandeau JP, Boitier E, Barouki R, Garlatti M. 2005. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces insulin-like growth factor binding protein-1 gene expression and counteracts the negative effect of insulin. Mol Pharmacol 67(2):444-452.
17. Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, et al. 2009. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 137(2):532-540.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412-419.
19. Mutch DM, Fuhrmann JC, Rein D, Wiemer JC, Bouillot JL, Poitou C, et al. 2009. Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery. PLoS One 4(11):e7905; doi:10.1371/journal.pone.0007905 [Online 19 November 2009].
20. Pelletier C, Imbeault P, Tremblay A. 2003. Energy balance and pollution by organochlorines and polychlorinated biphenyls. Obes Rev 4(1):17-24.
21. Piaggi S, Novelli M, Martino L, Masini M, Raggi C, Orciuolo E, et al. 2007. Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the beta-cell line INS-1E. Toxicol Appl Pharmacol 220(3):333-340.
22. Prat-Larquemin L, Oppert JM, Clement K, Hainault I, Basdevant A, Guy-Grand B, et al. 2004. Adipose angiotensinogen secretion, blood pressure, and AGT M235T polymorphism in obese patients. Obes Res 12(3):556-561.
23. Shimba S, Wada T, Tezuka M. 2001. Arylhydrocarbon receptor (AhR) is involved in negative regulation of adipose differentiation in 3T3-L1 cells: AhR inhibits adipose differentiation independently of dioxin. J Cell Sci 114(pt 15):2809-2817.
24. Siegel AB, Zhu AX. 2009. Metabolic syndrome and hepatocellular carcinoma. Cancer 115(24):5651-5661.
25. Tiniakos DG, Vos MB, Brunt EM. 2010. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 5:145-171.
26. Uemura H, Arisawa K, Hiyoshi M, Kitayama A, Takami H, Sawachika F, et al. 2009. Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population. Environ Health Perspect 117:568-573.
27. Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, et al. 2006. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93(2):223-241.
28. Viluksela M, Unkila M, Pohjanvirta R, Tuomisto JT, Stahl BU, Rozman KK, et al. 1999. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on liver phosphoenolpyruvate carboxykinase (PEPCK) activity, glucose homeostasis and plasma amino acid concentrations in the most TCDD-susceptible and the most TCDD-resistant rat strains. Arch Toxicol 73(6):323-336.
29. Wolff MS, Britton JA, Teitelbaum SL, Eng S, Deych E, Ireland K, et al. 2005. Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev 14(9):2224-2236.